The Towne strain is an attenuated, or weakened, form of human cytomegalovirus (CMV) developed for potential vaccine applications.
Vijay Samant, president and CEO of Vical, said: “CMV is an important target for Vical, and the Wistar technology adds to our already-strong intellectual property in this field.”